r.mcalister
TL3 Regular · Glasgow, UK
Retired process engineer. Interested in variability: between batches, between people, between weeks.
Joined 30 September 2024 · last posted 6d
132 posts, newest first. Showing up to 150.
-
Common supplements people ask about, assessed one at a time Replied, post #83 · Practice › Interactions · 22 Jul 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #59 · Analytics › HPLC & UHPLC · 22 Jul 2026 · 1 like This follows post #56 rather than contradicting it. Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not…
-
Seven-day rolling means and why weekly readings mislead Replied, post #82 · Outcomes › Progress reports · 22 Jul 2026 · 2 likes This follows post #79 rather than contradicting it. Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #14 · Compounds › Oral incretins · 21 Jul 2026 · 8 likes On post #10 — agreed on the reasoning, with one qualification. Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel.…
-
Seven-day rolling means and why weekly readings mislead Replied, post #61 · Outcomes › Progress reports · 19 Jul 2026 · 21 likes On post #57 — agreed on the reasoning, with one qualification. Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #41 · Access › Insurance & coverage · 18 Jul 2026 · 19 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #54 · Clinical › Comorbidities · 13 Jul 2026 · 3 likes On post #50 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
How to ask a question when you cannot say why you are asking it Replied, post #32 · Start Here › How to Ask · 6 Jul 2026 · 30 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #19 · Compounds › Secretagogues & GH axis · 2 Jul 2026 · 30 likes This follows post #16 rather than contradicting it. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might…
-
Packaging that arrived damaged: documenting it properly Replied, post #34 · Sourcing › Logistics · 1 Jul 2026 · 31 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Pages past their review date, listed — does this still hold? Replied, post #24 · Meta › Wiki maintenance · 24 Jun 2026 · 1 like Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
-
Does dual agonism explain the effect size, or is it dose? Replied, post #36 · Compounds › Tirzepatide · 14 Jun 2026 · 31 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Revisiting: The best-written scientific paper you have read Replied, post #27 · Lounge › Off topic · 12 Jun 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
CJC-1295 with and without DAC: what the modification does Replied, post #76 · Compounds › Secretagogues & GH axis · 6 Jun 2026 · 8 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #20 · Compounds › Secretagogues & GH axis · 1 Jun 2026 · 1 like post #19 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Prescription requirements and telehealth models — a second dataset Replied, post #49 · Sourcing › Regulatory · 1 Jun 2026 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #85 · Sourcing › Logistics · 30 May 2026 · 11 likes I read post #83 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Splitting an overlong document into two Replied, post #22 · Documentation › Wiki requests · 29 May 2026 · 1 like Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
What to include when your question involves a chromatogram — one year on Replied, post #13 · Start Here › How to Ask · 23 May 2026 · 3 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Transporting a vial for a weekend away — a second dataset Replied, post #51 · Practice › Storage & stability · 12 May 2026 · 1 like I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #110 · Practice › Interactions · 3 May 2026 · 28 likes post #109 answers the question as asked. The question underneath it is different. Supplements and herbs: many have no established interaction. Some do. If you are…
-
Research-use-only status: what it means legally and practically Replied, post #31 · Compounds › Other compounds · 22 Apr 2026 · 5 likes This follows post #28 rather than contradicting it. Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #3 · Outcomes › Body composition · 19 Apr 2026 · 0 likes post #2 answers the question as asked. The question underneath it is different. Changes during titration: measuring body composition during active titration is less…
-
List price versus negotiated price versus what you pay Replied, post #116 · Access › Pricing · 17 Apr 2026 · 0 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #11 · Practice › Reconstitution · 17 Apr 2026 · 0 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
List price versus negotiated price versus what you pay Replied, post #100 · Access › Pricing · 16 Apr 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Spike-and-recover accuracy for a peptide assay Replied, post #35 · Analytics › Method validation · 8 Apr 2026 · 21 likes Worth separating two things that post #31 runs together. Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate…
-
How to ask about something you suspect is a bad idea Replied, post #69 · Start Here › How to Ask · 25 Mar 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #75 · Practice › Reconstitution · 25 Mar 2026 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Grapefruit: why this class is not the class that cares Replied, post #76 · Practice › Interactions · 24 Mar 2026 · 29 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
A plateau that disappeared when I changed how I measured Replied, post #26 · Outcomes › Progress reports · 24 Mar 2026 · 32 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #50 · Research Methods › N-of-1 designs · 28 Feb 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #96 · Documentation › Wiki requests · 18 Feb 2026 · 6 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #4 · Practice › Dosing & titration · 15 Feb 2026 · 28 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #20 · Analytics › Mass spectrometry · 12 Feb 2026 · 1 like Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #31 · Practice › Reconstitution · 11 Feb 2026 · 20 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #26 · Outcomes › Progress reports · 9 Feb 2026 · 21 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Constipation management, with a dietitian's contribution Replied, post #25 · Practice › Side effects · 1 Feb 2026 · 9 likes Picking up post #22: that is the part I would want checked first. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #31 · Sourcing › Logistics · 1 Feb 2026 · 26 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #3 · Access › Pricing · 30 Jan 2026 · 16 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #26 · Research Methods › N-of-1 designs · 30 Jan 2026 · 0 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #106 · Clinical › Special populations · 26 Jan 2026 · 13 likes On post #102 — agreed on the reasoning, with one qualification. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #24 · Compounds › Oral incretins · 15 Jan 2026 · 4 likes Coming back to post #22, because the follow-up matters more than the original answer. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #120 · Practice › Side effects · 30 Dec 2025 · 13 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #25 · Sourcing › Red flags · 24 Dec 2025 · 3 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #23 · Sourcing › Regulatory · 8 Dec 2025 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #4 · Practice › Reconstitution · 4 Dec 2025 · 24 likes post #2 answers the question as asked. The question underneath it is different. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
Robustness: the parameters worth deliberately varying Replied, post #27 · Analytics › Method validation · 28 Nov 2025 · 0 likes Coming back to post #25, because the follow-up matters more than the original answer. Forced degradation studies: deliberately stress the material with acid, base,…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #54 · Sourcing › Regulatory · 28 Nov 2025 · 23 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Availability by country, dated, with primary sources Replied, post #79 · Access › International · 28 Nov 2025 · 14 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #64 · Analytics › Home & field testing · 27 Nov 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Whether protein timing matters at a large deficit Replied, post #4 · Nutrition & Training › Protein & intake · 22 Nov 2025 · 0 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #51 · Analytics › Home & field testing · 11 Nov 2025 · 27 likes On post #47 — agreed on the reasoning, with one qualification. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result.…
-
Absence of evidence and evidence of absence Replied, post #4 · Research Methods › Statistics · 2 Nov 2025 · 0 likes Confidence intervals: rather than a single point estimate, a range of plausible values. A narrow interval means precise measurement; a wide interval means measurement…
-
Citation sweep results: how many references did not say what was claimed Replied, post #2 · Meta › Wiki maintenance · 30 Oct 2025 · 0 likes Review dates: each maintained page has a review date (the date by which it should be checked). If a page is past its review date, flagging it here alerts the maintainer.
-
Thyroid function tests during substantial weight change Replied, post #112 · Clinical › Bloodwork · 28 Oct 2025 · 30 likes I read post #110 twice before replying, because I had assumed the opposite. Reference intervals: constructed to contain the central 95% of a reference population, which…
-
What pooling buys you and what it destroys Replied, post #48 · Evidence › Meta-analyses · 22 Oct 2025 · 1 like Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #103 · Start Here › Welcome · 22 Oct 2025 · 0 likes post #102 is right about the mechanism and I think understates the practical bit. Introducing yourself is fine and requires no question. Post in this subcategory,…
-
A 40-week log with the measurement method stated Replied, post #8 · Outcomes › Progress reports · 13 Oct 2025 · 0 likes Worth separating two things that post #4 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Specification in the result column: why that is a meaningful error Replied, post #57 · Analytics › COA interpretation · 12 Oct 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: German, French and Dutch differences, compared Replied, post #84 · Regional › European Union · 9 Oct 2025 · 1 like Coming back to post #82, because the follow-up matters more than the original answer. Cross-border purchase rules: buying a prescription in one EU country and bringing…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #20 · Start Here › How to Ask · 4 Oct 2025 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #42 · Practice › Storage & stability · 17 Sep 2025 · 23 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #36 · Analytics › COA interpretation · 15 Sep 2025 · 0 likes Coming back to post #34, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #123 · Practice › Reconstitution · 11 Sep 2025 · 14 likes Picking up post #120: that is the part I would want checked first. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #42 · Data & Tools › Datasets · 8 Sep 2025 · 11 likes post #41 answers the question as asked. The question underneath it is different. Collection methods: ask how the data were collected. Longitudinal tracking over months…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #20 · Evidence › Journal club · 6 Sep 2025 · 0 likes I read post #18 twice before replying, because I had assumed the opposite. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The…
-
Which panel is worth repeating and which is worth ignoring Replied, post #103 · Clinical › Bloodwork · 5 Sep 2025 · 0 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #8 · Data & Tools › Calculators · 28 Aug 2025 · 6 likes This follows post #5 rather than contradicting it. Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #15 · Practice › Side effects · 25 Aug 2025 · 15 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
Asking about a compound your prescriber has not heard of Replied, post #123 · Clinical › Prescriber conversations · 12 Aug 2025 · 6 likes post #122 answers the question as asked. The question underneath it is different. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #102 · Compounds › Semaglutide · 4 Aug 2025 · 4 likes Worth separating two things that post #98 runs together. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #100 · Compounds › Semaglutide · 3 Aug 2025 · 0 likes On post #96 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #46 · Practice › Dosing & titration · 2 Aug 2025 · 0 likes Coming back to post #44, because the follow-up matters more than the original answer. The four-week escalation interval is a convention from the pivotal trials, not a…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #23 · Compounds › Oral incretins · 1 Aug 2025 · 0 likes On post #19 — agreed on the reasoning, with one qualification. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #20 · Compounds › Secretagogues & GH axis · 29 Jul 2025 · 11 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
Are there stupid questions here? A staff answer, at length Replied, post #5 · marked as the solution · Start Here › Welcome · 22 Jul 2025 · 8 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Canadian access and provincial variation — one year on Replied, post #5 · Regional › North America · 18 Jul 2025 · 0 likes United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans,…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #98 · Practice › Reconstitution · 10 Jul 2025 · 11 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
What this community means by "a source", in practical terms Replied, post #23 · Start Here › Welcome · 3 Jul 2025 · 1 like This follows post #20 rather than contradicting it. Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #13 · Compounds › Semaglutide · 1 Jul 2025 · 11 likes I read post #11 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
A comparison of home results against a laboratory result on the same vial Replied, post #8 · Analytics › Home & field testing · 24 Jun 2025 · 25 likes I read post #6 twice before replying, because I had assumed the opposite. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #71 · Practice › Storage & stability · 24 Jun 2025 · 26 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #16 · Compounds › Secretagogues & GH axis · 17 Jun 2025 · 4 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Coming back to: Getting a referral rather than a refusal Replied, post #48 · Clinical › Prescriber conversations · 9 Jun 2025 · 0 likes Coming back to post #46, because the follow-up matters more than the original answer. Clarifying indication: if a compound is approved for diabetes but you have obesity…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #5 · Pharmacology › Receptor biology · 8 Jun 2025 · 20 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
Half-life, steady state, and accumulation worked through Replied, post #80 · Pharmacology › Pharmacokinetics · 7 Jun 2025 · 0 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Specification in the result column: why that is a meaningful error Replied, post #3 · Analytics › COA interpretation · 25 May 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
One lot is one lot: when a report becomes a pattern Replied, post #3 · Sourcing › Vendor reports · 25 May 2025 · 0 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #86 · Outcomes › Body composition · 23 May 2025 · 9 likes I read post #84 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Publishing an inconvenient result: a case study Replied, post #23 · Sourcing › Independent verification · 22 May 2025 · 31 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #65 · Outcomes › Body composition · 19 May 2025 · 21 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #64 · Compounds › Secretagogues & GH axis · 17 May 2025 · 28 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
Subcutaneous absorption kinetics and site differences Replied, post #3 · Pharmacology › Pharmacokinetics · 15 May 2025 · 12 likes This follows post #2 rather than contradicting it. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #36 · Clinical › Comorbidities · 9 May 2025 · 3 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #4 · Clinical › Special populations · 2 May 2025 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Hepatic impairment: less is known about dosing in significant liver…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #81 · Access › Pricing · 28 Apr 2025 · 0 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #31 · Data & Tools › Calculators · 24 Apr 2025 · 16 likes On post #27 — agreed on the reasoning, with one qualification. The calculators maintained on this site are open-source and verifiable. They are intended to check…
-
Hello from a laboratory that does not do peptides Replied, post #5 · Lounge › Introductions · 21 Apr 2025 · 5 likes I read post #3 twice before replying, because I had assumed the opposite. Following up: if you introduce yourself and someone asks a follow-up question, you can reply…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #59 · Evidence › Journal club · 20 Apr 2025 · 7 likes Worth separating two things that post #55 runs together. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #65 · Compounds › Tirzepatide · 20 Apr 2025 · 31 likes I read post #63 twice before replying, because I had assumed the opposite. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance…
-
A report I filed that turned out to be wrong, and the correction Replied, post #17 · Sourcing › Vendor reports · 17 Apr 2025 · 1 like Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
-
Micronutrient status when intake falls substantially Started this topic · Clinical › Bloodwork · 14 Apr 2025 · 6 likes On the subject in the title: Micronutrient status when intake falls substantially Working notes rather than a conclusion. Asking about a population rather than about a…
-
Carryover and the ghost peak from last week's standard Replied, post #77 · Analytics › HPLC & UHPLC · 10 Apr 2025 · 8 likes On post #73 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Retatrutide dose escalation in the published trials Replied, post #81 · Compounds › Retatrutide · 2 Apr 2025 · 0 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #137 · Analytics › COA interpretation · 29 Mar 2025 · 0 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
When to suspect the method rather than the sample Replied, post #98 · Analytics › Method validation · 16 Mar 2025 · 9 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #73 · Evidence › Meta-analyses · 8 Feb 2025 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Scheduled maintenance and what will be unavailable Replied, post #34 · Meta › Announcements · 5 Feb 2025 · 8 likes On post #30 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #11 · Practice › Reconstitution · 3 Feb 2025 · 28 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Protein density versus volume when you cannot eat much Replied, post #35 · Nutrition & Training › Protein & intake · 29 Jan 2025 · 0 likes I read post #33 twice before replying, because I had assumed the opposite. Eating anything at all: on substantial appetite suppression, eating enough total calories to…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 17 Jan 2025 · 32 likes On post #10 — agreed on the reasoning, with one qualification. Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and…
-
Fixed versus detachable needles: the trade-offs Replied, post #90 · Devices › Syringes & needles · 4 Jan 2025 · 30 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Isotonicity and what happens when you get it wrong Replied, post #16 · Pharmacology › Formulation chemistry · 3 Jan 2025 · 6 likes Antioxidants: compounds that prevent oxidation (which damages peptides) are sometimes included. Methionine oxidation is a common degradation pathway and antioxidants…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #13 · Compounds › Oral incretins · 1 Jan 2025 · 18 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #87 · Access › Insurance & coverage · 25 Dec 2024 · 21 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Body image changing more slowly than the body Replied, post #122 · Wellbeing › Mental health · 24 Dec 2024 · 0 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #25 · Compounds › Semaglutide · 20 Dec 2024 · 15 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Body image changing more slowly than the body Replied, post #36 · Wellbeing › Mental health · 15 Dec 2024 · 8 likes Worth separating two things that post #32 runs together. When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function,…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #57 · Nutrition & Training › Protein & intake · 14 Dec 2024 · 0 likes Coming back to post #55, because the follow-up matters more than the original answer. Micronutrition alongside protein: eating protein foods that are also good sources…
-
Why "any advice?" is the least effective ending for a post Replied, post #76 · Start Here › How to Ask · 26 Nov 2024 · 1 like Worth separating two things that post #72 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Transit times by route, from a logged dataset — the long version Replied, post #29 · Sourcing › Logistics · 13 Nov 2024 · 7 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #47 · Clinical › Prescriber conversations · 10 Nov 2024 · 1 like This follows post #44 rather than contradicting it. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this…
-
Time to steady state after a dose increase Replied, post #148 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes post #147 is right about the mechanism and I think understates the practical bit. Individual variation: people vary in how quickly they absorb, distribute, metabolise,…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #108 · Analytics › COA interpretation · 6 Nov 2024 · 0 likes I read post #106 twice before replying, because I had assumed the opposite. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #7 · Practice › Interactions · 6 Nov 2024 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #18 · Clinical › Prescriber conversations · 30 Oct 2024 · 27 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #14 · Practice › Interactions · 6 Oct 2024 · 3 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Promotion criteria, and the one that stops most nominations Replied, post #76 · Documentation › Doc review · 3 Oct 2024 · 9 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #27 · Sourcing › Independent verification · 31 Aug 2024 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Promotion criteria, and the one that stops most nominations Replied, post #43 · Documentation › Doc review · 21 Aug 2024 · 11 likes Coming back to post #41, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #79 · Compounds › Retatrutide · 21 Jul 2024 · 0 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…